Coptisine (Protoberberine Alkaloid · Antimicrobial · Neuroprotective)

Compound	Coptisine
Chemical class	Alkaloid — Isoquinoline (Protoberberine, Berberine Analogue)
CAS	3486-66-6
Primary source	Coptis chinensis (Huang Lian / Chinese goldthread), Chelidonium majus
Key applications	Antimicrobial, anti-inflammatory, blood glucose, neuroprotective
Claim strength	Moderate
Typical form	Coptis chinensis extract (berberine-dominant with coptisine co-present)
Buy from Herbuno	Contact Herbuno for sourcing enquiries →

Commercial source: Coptisine is commercially available as a co-constituent of Coptis chinensis rhizome extract, standardised primarily to berberine content. Coptisine constitutes approximately 5–10% of the total alkaloid fraction in Coptis extract. Isolated coptisine is available from specialist chemical suppliers. See sourcing options below. Traditional use: Coptis chinensis (Huang Lian, Chinese goldthread) is one of the most important anti-inflammatory and anti-infective herbs in TCM, used for over 3,000 years for diarrhoea, dysentery, gastroenteritis, and as an antipyretic and antimicrobial. The bright yellow colour of Huang Lian roots reflects the high protoberberine alkaloid content — berberine is dominant, but coptisine, palmatine, and worenine are significant co-alkaloids. Research trajectory: Coptisine has a growing research profile distinct from berberine, with documented anti-neuroinflammatory, anti-adipogenic, and platelet aggregation-inhibiting mechanisms. Its AMPK activation and glucose-lowering activity parallel berberine but with potentially different tissue distribution due to structural differences. See sourcing options below.

---

Evidence for Coptisine Applications

Antimicrobial: Coptisine inhibits DNA gyrase and topoisomerase IV in bacteria — mechanisms shared with berberine — and shows broad-spectrum antibacterial activity (MIC values 4–64 µg/mL against common pathogens). Antifungal activity against Candida species and anti-MRSA activity are documented. Contributes to Huang Lian’s traditional antimicrobial application. Claim strength: Moderate.

Anti-neuroinflammatory and neuroprotective: Coptisine inhibits microglial NF-κB activation and reduces neuroinflammatory cytokine production more potently than berberine in some comparative assays — attributed to different receptor binding due to coptisine’s methylenedioxy ring versus berberine’s methoxy groups. Amyloid-beta aggregation inhibition is documented. Claim strength: Moderate.

Blood glucose and lipid: Coptisine activates AMPK and inhibits alpha-glucosidase, producing glucose-lowering effects in diabetic animal models. Lipid-lowering activity through PCSK9 pathway (shared with berberine) is documented in cell models. Claim strength: Moderate.

---

Dosage & Formulator Specification

Coptisine is not formulated as a standalone supplement. In Coptis chinensis extract standardised to berberine content, coptisine is co-present at approximately 5–10% of total alkaloids. For a 500 mg berberine (95%) daily dose, co-delivered coptisine from Coptis-sourced berberine extract is negligible (<5% of the total alkaloid from a 98% HCl pure form). Coptisine-specific activity is most relevant in the context of the full Coptis chinensis alkaloid complex.

For formulators specifically targeting coptisine’s differentiated neuroprotective activity, isolated coptisine (≥98% HPLC) is available from specialist chemical suppliers at research scale. The most practical commercial approach is to specify Coptis chinensis root extract standardised to total alkaloids (including berberine, coptisine, palmatine) rather than using isolated coptisine.

---

Frequently Asked Questions — Coptisine

Is coptisine the same as berberine?
No. Coptisine and berberine are both protoberberine isoquinoline alkaloids found in Coptis chinensis, but they are structurally distinct. Berberine has two methoxy groups (at 9 and 10 positions); coptisine has a methylenedioxy ring system (at positions 9,10). This structural difference results in different metabolic handling, receptor affinity profiles, and enzyme interaction characteristics. They share the yellow chromophore and core protoberberine scaffold, and overlap substantially in antimicrobial and blood glucose mechanisms.

Does coptisine contribute to Huang Lian’s clinical effects independently of berberine?
Research suggests that the full Huang Lian alkaloid complex — including coptisine alongside berberine, palmatine, and worenine — may provide synergistic or complementary activity beyond berberine alone. The anti-neuroinflammatory profile of coptisine suggests it may contribute to cognitive and neuroprotective aspects of Coptis extract not fully accounted for by berberine alone.

Can Coptis chinensis extract be used instead of isolated berberine?
Yes — and there is an argument for the full alkaloid complex over isolated berberine. Coptis chinensis root extract standardised to total alkaloids delivers berberine as the dominant active alongside coptisine, palmatine, and worenine as complementary alkaloids. This aligns with the traditional botanical preparation and may provide broader pharmacological coverage than isolated berberine HCl. Trade-off: less precise berberine dosing and higher cost per mg berberine equivalent.

Is there a specific coptisine product on the market?
No widely marketed supplement featuring coptisine as the primary declared active exists. Coptisine is marketed as a research chemical and is a component of Coptis and Huang Lian alkaloid complex extracts. The supplement market infrastructure for coptisine as a primary ingredient is not yet established at commercial supplement scale.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery